Unknown

Dataset Information

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies.


ABSTRACT: Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of cytotoxic treatments for underlying malignancies.

SUBMITTER: Tavitian S 

PROVIDER: S-EPMC4517705 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature